Related Experiment Video
Updated: Jun 27, 2025

15:27
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
20.8K
Antibody association in solution: cluster distributions and mechanisms
Sandi Brudar1, Leonid Breydo2, Elisha Chung2
1Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Mabs
|April 26, 2024
Summary
High viscosity in monoclonal antibody solutions is linked to increased antibody clustering. This study connects molecular interactions to solution properties, aiding therapeutic development.
Area of Science:
- Biophysics
- Physical Chemistry
- Protein Science
Background:
- Understanding antibody solution behavior is crucial for therapeutic development.
- Factors influencing antibody molecule clustering and association impact drug efficacy.
Purpose of the Study:
- To investigate the relationship between antibody concentration and solution properties like viscosity and clustering.
- To evaluate theoretical models for predicting antibody solution behavior.
Main Methods:
- Measured viscosity, second virial coefficients, Kirkwood-Buff integrals, and cluster distributions for 19 monoclonal antibody (mAb) solutions.
- Modeled solutions using statistical-physics Wertheim liquid-solution theory with Y-shaped antibody representations.
- Analyzed antibody-antibody interactions and their impact on solution properties.
Main Results:
- High solution viscosity correlates with a greater number of antibody molecules per cluster.
- Viscosity is accurately predicted by the 2-body Kirkwood-Buff quantity (G22), not the second virial coefficient (B22).
- Theoretical predictions based on Wertheim theory align well with experimental protein-protein sticking energy.
Conclusions:
- The study establishes a link between molecular-level interactions and macroscopic solution properties for associating proteins.
- This framework aids in predicting and controlling antibody solution behavior for therapeutic applications.
- Insights into nucleation and propagation rates inform the development of antibody-based therapeutics.
Related Concept Videos
Antibody Structure
60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Antibody Structure and Classes
890
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
890
Affinity and Avidity
36.0K
Overview
36.0K
Humoral Immune Responses
72.6K
Overview
72.6K

